Editas Medicine (EDIT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.5400 -0.0700 (-4.35%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.5100 -0.0300 (-1.95%) 17:36 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -237,093 | -153,219 | -220,432 | -192,502 | -115,976 |
| Depreciation Amortization | 18 | 1,241 | 5,613 | 6,710 | 3,959 |
| Accounts receivable | -6,079 | -5,042 | -4,878 | 5,781 | -5,630 |
| Accounts payable and accrued liabilities | -2,286 | -1,492 | 4,368 | -1,139 | 855 |
| Other Working Capital | 3,450 | -1,594 | 8,176 | -21,410 | -102,220 |
| Other Operating Activity | 31,706 | 27,928 | 29,804 | 38,757 | 39,169 |
| Operating Cash Flow | $-210,284 | $-132,178 | $-177,349 | $-163,803 | $-179,843 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 170,972 | 988 | 118,168 | -46,489 | -153,404 |
| PPE Investments | -8,826 | -4,719 | -4,100 | -7,977 | -7,150 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 20,032 |
| Investing Cash Flow | $162,146 | $-3,731 | $114,068 | $-54,466 | $-140,522 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 783 | 118,039 | 1,284 | 282,106 | 224,122 |
| Other Financing Activity | 55,244 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $56,027 | $118,039 | $1,284 | $282,106 | $224,122 |
| Beginning Cash Position | 127,529 | 145,399 | 207,396 | 143,559 | 239,802 |
| End Cash Position | 135,418 | 127,529 | 145,399 | 207,396 | 143,559 |
| Net Cash Flow | $7,889 | $-17,870 | $-61,997 | $63,837 | $-96,243 |
| Free Cash Flow | |||||
| Operating Cash Flow | -210,284 | -132,178 | -177,349 | -163,803 | -179,843 |
| Capital Expenditure | -8,826 | -4,719 | -4,118 | -7,977 | -7,162 |
| Free Cash Flow | -219,110 | -136,897 | -181,467 | -171,780 | -187,005 |